Redx Pharma (Rights, titles, interests and patents of pan-RAF inhibitor program) is Buildings and Property in United Kingdom that focus on pan - RAF business. They cover business area such as right, title, interest, patent, pan-RAF inhibitor program, cancer treatment.
-
Pan - RAF
-
Block 33, Mereside
Alderley Park, Alderley Edge
Macclesfield SK10 4TG
England, United Kingdom
Private
righttitleinterestpatentpan-RAF inhibitor programcancer treatment
* We use standard office opening hours in near Redx Pharma (Rights, titles, interests and patents of pan-RAF inhibitor program)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Redx Pharma (Rights, Titles, Interests And Patents Of Pan-RAF Inhibitor Program) is Buildings and Property business from United Kingdom that founded in - ( years old in ), Redx Pharma (Rights, titles, interests and patents of pan-RAF inhibitor program) business is focusing on Pan - RAF.
Redx Pharma (Rights, titles, interests and patents of pan-RAF inhibitor program) headquarter office and corporate office address is located in Block 33, Mereside Alderley Park, Alderley Edge Macclesfield SK10 4TG England, United Kingdom.
Redx Pharma (Rights, titles, interests and patents of pan-RAF inhibitor program) was founded in United Kingdom.
In , Redx Pharma (Rights, titles, interests and patents of pan-RAF inhibitor program) is currently focus on pan - RAF sector.
Above is snippet of Google Trends for "pan - RAF" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Redx Pharma (Rights, titles, interests and patents of pan-RAF inhibitor program), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
